Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Leukemia

  Free Subscription


Articles published in Exp Hematol

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    November 2021
  1. KENSWIL KJG, Pisterzi P, Feyen J, Ter Borg M, et al
    Immune composition and its association with hematologic recovery after chemotherapeutic injury in acute myeloid leukemia.
    Exp Hematol. 2021 Nov 17. pii: S0301-472X(21)00426.
    PubMed     Abstract available


    September 2021
  2. TREMBLAY CS, Ting SB, McCluskey A, Robinson PJ, et al
    Shutting the gate: targeting endocytosis in acute leukemia.
    Exp Hematol. 2021 Sep 23. pii: S0301-472X(21)00326.
    PubMed    


  3. LIAO W, Eric Kohler M, Fry T, Ernst P, et al
    Corrigendum to : <[Experimental Hematology 2021; 100: 1-11]>.
    Exp Hematol. 2021 Sep 20. pii: S0301-472X(21)00293.
    PubMed    


    July 2021
  4. HONDA A, Koya J, Yoshimi A, Miyauchi M, et al
    Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemia.
    Exp Hematol. 2021 Jul 29. pii: S0301-472X(21)00280.
    PubMed     Abstract available


  5. LIAO W, Kohler ME, Fry T, Ernst P, et al
    Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia.
    Exp Hematol. 2021 Jul 21. pii: S0301-472X(21)00248.
    PubMed     Abstract available


    June 2021
  6. KAEHLER M, Dworschak M, Rodin JP, Ruemenapp J, et al
    ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells.
    Exp Hematol. 2021 Jun 3. pii: S0301-472X(21)00199.
    PubMed     Abstract available


  7. MACBETH KJ, Chopra VS, Tang L, Zheng B, et al
    Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNA.
    Exp Hematol. 2021;98:47-52.
    PubMed     Abstract available


    May 2021
  8. GRANDITS AM, Wieser R
    Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.
    Exp Hematol. 2021 May 21. pii: S0301-472X(21)00195.
    PubMed     Abstract available


  9. YOKOMIZO-NAKANO T, Sashida G
    Two faces of RUNX3 in myeloid transformation.
    Exp Hematol. 2021;97:14-20.
    PubMed     Abstract available


  10. DI GENUA C, Nerlov C
    To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice.
    Exp Hematol. 2021;97:6-13.
    PubMed     Abstract available


    March 2021
  11. MONDET J, Presti CL, Chevalier S, Bertrand A, et al
    Mitochondria in human acute myeloid leukemia cell lines have ultrastructural alterations linked to deregulation of their respiratory profiles.
    Exp Hematol. 2021 Mar 6. pii: S0301-472X(21)00095.
    PubMed     Abstract available


    February 2021
  12. VILLAUME MT, Arrate MP, Ramsey HE, Sunthankar KI, et al
    The delta isoform of PI3K predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib.
    Exp Hematol. 2021 Feb 19. pii: S0301-472X(21)00089.
    PubMed     Abstract available


  13. SWART LE, Heidenreich O
    The RUNX1/RUNX1T1 network: translating insights into therapeutic options.
    Exp Hematol. 2021;94:1-10.
    PubMed     Abstract available


    January 2021
  14. WEI H, Liu X, Wang Y, Lin D, et al
    The Optimized Clinical Application of Minimal Residual Disease in Acute Myeloid Leukemia with RUNX1-RUNX1T1.
    Exp Hematol. 2021 Jan 29. pii: S0301-472X(21)00032.
    PubMed     Abstract available


  15. BATSIVARI A, Grey W, Bonnet PD
    Understanding of the crosstalk between normal residual hematopoietic stem cells and the leukemic niche in Acute Myeloid Leukemia.
    Exp Hematol. 2021 Jan 23. pii: S0301-472X(21)00026.
    PubMed     Abstract available


  16. RUSSKAMP NF, Myburgh R, Kiefer JD, Neri D, et al
    Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells.
    Exp Hematol. 2021 Jan 20. pii: S0301-472X(21)00004.
    PubMed     Abstract available


  17. MAKI H, Yoshimi A, Shimada T, Arai S, et al
    Physical interaction between BAALC and DBN1 induces chemoresistance in leukemia.
    Exp Hematol. 2021 Jan 14. pii: S0301-472X(20)30666.
    PubMed     Abstract available


  18. MILONE G, Scire P, Camuglia MG, Triolo A, et al
    LOW CONTENT OF CLONOGENIC PROGENITORS ON DAY+18, IS ASSOCIATED WITH ACUTE GRAFT VERSUS HOST DISEASE AND PREDICT TRANSPLANT RELATED MORTALITY.
    Exp Hematol. 2021 Jan 11. pii: S0301-472X(21)00003.
    PubMed     Abstract available


  19. BLANCO G, Puiggros A, Sherry B, Nonell L, et al
    CLL-like monoclonal B cell lymphocytosis displays an increased inflammatory signature that is reduced in early stage chronic lymphocytic leukemia.
    Exp Hematol. 2021 Jan 6. pii: S0301-472X(21)00001.
    PubMed     Abstract available


  20. AREDE L, Pina C
    Buffering noise: KAT2A modular contributions to stabilization of transcription and cell identity in cancer and development.
    Exp Hematol. 2021;93:25-37.
    PubMed     Abstract available


    November 2020
  21. CHIN PS, Assi SA, Ptasinska A, Imperato MR, et al
    RUNX1/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) acute myeloid leukemia.
    Exp Hematol. 2020 Nov 2. pii: S0301-472X(20)30618.
    PubMed     Abstract available


    October 2020
  22. SYMEONIDOU V, Ottersbach K
    HOXA9/IRX1 expression pattern defines two sub-groups of infant MLL-AF4-driven Acute Lymphoblastic Leukemia.
    Exp Hematol. 2020 Oct 15. pii: S0301-472X(20)30593.
    PubMed     Abstract available


  23. FITCH B, Roy R, Geng H, Montecino-Rodriguez E, et al
    Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature.
    Exp Hematol. 2020;90:65-71.
    PubMed     Abstract available


    September 2020
  24. HENGEVELD PJ, Levin MD, Kolijn PM, Langerak AW, et al
    Reading the B cell receptor Immunome in Chronic Lymphocytic Leukemia: Revelations and Applications.
    Exp Hematol. 2020 Sep 22. pii: S0301-472X(20)30559.
    PubMed     Abstract available


  25. BOILA LD, Sengupta A
    Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
    Exp Hematol. 2020 Sep 17. pii: S0301-472X(20)30554.
    PubMed     Abstract available


  26. JACOBS S, Ausema A, Zwart E, Weersing E, et al
    Detection of chemotherapy-resistant patient-derived acute lymphoblastic leukemia clones in murine xenografts using cellular barcodes.
    Exp Hematol. 2020 Sep 15. pii: S0301-472X(20)30553.
    PubMed     Abstract available


  27. TANAKA Y, Mikami K, Adachi K, Fukushima T, et al
    Efficacy of tyrosine kinase inhibitors on a mouse chronic myeloid leukemia model and chronic myeloid leukemia stem cells.
    Exp Hematol. 2020 Sep 7. pii: S0301-472X(20)30548.
    PubMed     Abstract available


  28. YOUNG K, Loberg MA, Eudy E, Schwartz LS, et al
    Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.
    Exp Hematol. 2020;89:61-67.
    PubMed     Abstract available


  29. ZANETTI C, Krause DS
    "Caught in the net": the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia.
    Exp Hematol. 2020;89:13-25.
    PubMed     Abstract available


  30. KANIYATTU SM, Meenakshi A, Kumar MB, Kumar KR, et al
    Cytogenetic and cytokine profile in elderly patients with cytopenia.
    Exp Hematol. 2020;89:80-86.
    PubMed     Abstract available


    August 2020
  31. LIN H, Damen JE, Walasek MA, Szilvassy SJ, et al
    A Feeder-Free and Serum-Free In Vitro Assay for Measuring the Effect of Drugs on Acute and Chronic Myeloid Leukemia Stem/Progenitor Cells.
    Exp Hematol. 2020 Aug 13. pii: S0301-472X(20)30349.
    PubMed     Abstract available


  32. HOSNIJEH FS, van der Straten L, Kater AP, van Oers MHJ, et al
    Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy; results from the HOVON 109 study.
    Exp Hematol. 2020 Aug 8. pii: S0301-472X(20)30308.
    PubMed     Abstract available


    July 2020
  33. BOTTARDI S, Guieze R, Bourgoin V, Fotouhi-Ardakani N, et al
    MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells.
    Exp Hematol. 2020 Jul 16. pii: S0301-472X(20)30269.
    PubMed     Abstract available


  34. YAN B, Claxton D, Huang S, Qiu Y, et al
    AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.
    Exp Hematol. 2020;87:13-19.
    PubMed     Abstract available


  35. DEUTSCH JL, Heath JL
    MLLT10 in benign and malignant hematopoiesis.
    Exp Hematol. 2020;87:1-12.
    PubMed     Abstract available


    June 2020
  36. HE X, Dou A, Feng S, Roman-Rivera A, et al
    Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitro.
    Exp Hematol. 2020;86:21-27.
    PubMed     Abstract available


    May 2020
  37. SINHA R, Porcheri C, d'Altri T, Gonzalez J, et al
    Development of embryonic and adult leukemia mouse models driven by MLL-ENL translocation.
    Exp Hematol. 2020 May 10. pii: S0301-472X(20)30146.
    PubMed     Abstract available


  38. LENARD A, Xie HM, Pastuer T, Shank T, et al
    Epigenetic regulation of protein translation in KMT2A-rearranged AML.
    Exp Hematol. 2020;85:57-69.
    PubMed     Abstract available


    April 2020
  39. PAGLIARO S, Desterke C, Acloque H, Chomel JC, et al
    SINGLE CELL TRANSCRIPTOME IN CHRONIC MYELOID LEUKEMIA (CML): PSEUDOTIME ANALYSIS REVEALS EVIDENCE OF EMBRYONIC AND TRANSITIONAL STEM CELL STATES.
    Exp Hematol. 2020 Apr 28. pii: S0301-472X(20)30142.
    PubMed     Abstract available


  40. RAZ O, Granot G, Pasmanik-Chor M, Raanani P, et al
    Profiling and Bioinformatics Analyses Reveal Chronic Lymphocytic Leukemia Cells Share a Unique Circular RNA Expression Pattern.
    Exp Hematol. 2020 Apr 10. pii: S0301-472X(20)30137.
    PubMed     Abstract available


    March 2020
  41. SWIERCZEK S, Prchal JT
    Clonal hematopoiesis in hematological disorders: Three different scenarios.
    Exp Hematol. 2020;83:57-65.
    PubMed     Abstract available


  42. COOK EK, Luo M, Rauh MJ
    Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity.
    Exp Hematol. 2020;83:85-94.
    PubMed     Abstract available


    February 2020
  43. KRONSTEIN-WIEDEMANN R, Klop O, Thiel J, Milanov P, et al
    K562 erythroleukemia line as a possible reticulocyte source to culture Plasmodium vivax and its surrogates.
    Exp Hematol. 2020;82:8-23.
    PubMed     Abstract available


    January 2020
  44. LEE-SIX H, Kent DG
    Tracking hematopoietic stem cells and their progeny using whole-genome sequencing.
    Exp Hematol. 2020 Jan 30. pii: S0301-472X(20)30024.
    PubMed     Abstract available


  45. AKAHOSHI Y, Nakasone H, Kawamura K, Kusuda M, et al
    Detection of T315I using digital polymerase chain reaction in allogeneic transplant recipients with Ph-positive acute lymphoblastic anemia in the dasatinib era.
    Exp Hematol. 2020 Jan 11. pii: S0301-472X(20)30001.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: